Thompson G A, Myers J A, Turner P A, Denson D D, Coyle D E, Ritschel W A
Drug Metab Dispos. 1984 Sep-Oct;12(5):625-30.
Recent reports have appeared describing a cimetidine-induced alteration in either the input or disposition function for many drugs. The total clearance component of the disposition function is the primary perturbation. In the present investigation, the influence of cimetidine on bupivacaine disposition was studied, using in vitro and in vivo models. Since the extraction ratio for bupivacaine is low, total clearance follows the capacity-limited theory. Hence, the influence of cimetidine on the intrinsic clearance of bupivacaine was assessed using microsome and hepatocyte models. Results for both systems are in excellent agreement and indicate a noncompetitive inhibition. Additionally, the influence of cimetidine on the protein-binding profile of bupivacaine was determined. In the presence of cimetidine, the these findings was assessed in vivo in rhesus monkeys. co-administration of cimetidine resulted in an increase in the volume of distribution at steady state and no change in the total clearance of bupivacaine.
最近有报道描述了西咪替丁对许多药物的输入或处置功能的影响。处置功能的总清除率部分是主要的干扰因素。在本研究中,使用体外和体内模型研究了西咪替丁对布比卡因处置的影响。由于布比卡因的提取率较低,总清除率遵循容量限制理论。因此,使用微粒体和肝细胞模型评估了西咪替丁对布比卡因内在清除率的影响。两个系统的结果非常一致,并表明存在非竞争性抑制。此外,还确定了西咪替丁对布比卡因蛋白结合谱的影响。在西咪替丁存在的情况下,在恒河猴体内评估了这些发现。西咪替丁的共同给药导致稳态分布容积增加,而布比卡因的总清除率没有变化。